Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Bronchodilation is well maintained in patients with chronic obstructive pulmonary disease (COPD) using the long-acting beta-2-agonist indacaterol during 1 year of treatment, investigators…
NEW YORK (Reuters Health) – An investigational drug AMR101 containing purified eicosapentaenoic acid and no docosahexaenoic acid reduces very high triglyceride levels by up to 45% compared to…
NEW YORK (Reuters Health) – While angiotensin receptor blockers (ARBs) as a class do not appear to be associated with an increased malignancy risk in patients with diabetes,…
NEW YORK (Reuters Health) – Patients with moderate-to-severe chronic obstructive pulmonary disease have a greater improvement in dyspnea and health status after 12 weeks of treatment with inhaled…
NEW YORK (Reuters Health) – A review of available evidence indicates that colchicine given after cardiac surgery reduces the risk of developing post-pericardiotomy syndrome, or PPS. “The data…
NEW YORK (Reuters Health) – Results of a Mexican study indicate that 2 months of treatment with the antiinflammatory agent diacerein increases insulin secretion and improves A1C levels…
NEW YORK (Reuters Health) – For patients with acute MI given early unfractionated heparin, a switch to bivalirudin before undergoing primary percutaneous coronary intervention results in improved cardiac…
NEW YORK (Reuters Health) – The use of inhaled anticholinergic drugs to treat chronic obstructive pulmonary disease (COPD) is associated with an increased risk of developing urinary retention…
NEW YORK (Reuters Health) – In ischemic stroke patients weighing more than 100 kg, the fixed maximum dose limit for intravenous recombinant tissue plasminogen activator (rTPA — alteplase)…
NEW YORK (Reuters Health) – There’s now one more reason for statin loading before percutaneous coronary intervention. As well as reducing myocardial damage, high-dose atorvastatin given shortly before…
